Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
- Triggering Signals of BRCA1 Breast Cancer (K Kessenbrock)
- Testing Diverse Groups Finds New Breast Cancer Genes (L Teras)
- Black Women & Genetic Testing (J Palmer)
- Women 65+ & Genetic Tests for Breast Cancer Risk (L Teras)
- High-Risk Genes and Screening (A Patel)
- New Risk Calculation May Affect Breast Cancer Screening (L Teras)
- Black Men and Breast Cancer (H Sung)
- Platelets May Help Breast Cancer Spread (E Battinelli)
- Natural Killer Cells & TNBC (R. Chakrabarti)
- Improving Chemotherapy (O Sahin)
- Combo Treatment for TNBC (K Varley)
- Treatments Attack Cell Division (A Holland)
- ER+ Treatment in Mice (P Kenny)
- Blood DNA Monitors Metastasis Treatment (H P Ji)
- PTK6 Gene as Treatment Target (H Irie)
- Time-Lapse Cell Movies (S Spencer)
- 3D Mini Breast Tumors May Help ID New Cancer Treatments
- AI Tool Improves Breast Cancer Prognosis Accuracy
- Exercise & Sitting Time (E. Rees-Punia)
- Cancer Risk Factors in LGBTQ Populations (B. Charlton)
- CPS-3 Disparities Studies
- Cancer Disparities in the US (F. Islami)
- Housing Assistance and Mammograms (H Lee)
- Clinical Trial Treatment Cost App (L Hamel)
- Podcasts, TheoryLab
- Patients Health Insurance Tool (M. Politi)
- Breast Cancer Treatment in Ethiopia (A. Jemal)
- Better Survival Requires Better Insurance (J Zhao)
- Medicaid Eligibility Limits (J Zhao)
- New Treatment for Neuroblastoma (A Heczey)
- Oncogenic Fusions AML (S Meshinchi)
- Genetic Risks (L Teras)
- New Medulloblastoma Drugs (J Rodriguez-Blanco)
- Potential New Hope for MLL (J Grembecka)
- Increase in Brain Tumor Diagnosis (K Miller)
- Longer Life Expectancy for Survivors (J Yeh)
- Potential Target for New Osteosarcoma Drugs (C Benavente)
- At-Home Chemo for Children with HR ALL (L Ranney)
- Childhood Cancer Research Landscape Report
- Tumor-Infiltrating Neutrophils (R. Sumagin)
- New Epigenetic Target (K Rai)
- Extra Chromosomes (Aneuploidy) Effect on Cancer (J. Sheltzer)
- Discovery of a New Biomarker Is the First Step to New Treatment (C. Maher)
- Designer Virus Targets and Kills CRC Cells in Mice (S. Warner)
- Tiny Sensor in Mice May Find Cancer That's Trying to Spread (L. Hao)
- Targeting a Protein “Turned on” by Mistake (N. Gao)
- Spatial Map Intestines (J Hickey)
- CRC Treatment Podcasts
- Keto Molecule & Colorectal Cancer (M Levy)
- Availability of Healthy Food (L Tussing-Humphreys)
- 45 Min/Day of Physical Activity (A Minihan)
- Fewer than 10K Steps/Day (A Patel)
- Yogurt & Cheese & ER- Breast Cancer (M McCullough)
- Stage 2 Clinical Trials for New Endometrial Cancer Drug (V Bae-Jump)
- Hard-to-Starve Pancreatic Cancer Cells (N Kalaany)
- Coffee Risks for Colorectal Cancer (C Um)
- Food Parasite & Brain Cancer Risk (J Hodge)
- Exercise & Quality of Life in Older Survivors (E Rees-Punia)
- 21 Metabolites Linked with Breast Cancer (Y Wang)
- Replacing Sitting May Affect Weight (E Rees-Punia)
- CPS-3 Researchers Ask What People Eat and Check Urine Samples (Y Wang)
- Video Games Motivate Exercise? (E. Lyons)
- Food Choices and Colon Cancer Risk (P. Chandler)
- Race, Exercise & Breast Cancer (C. Dallal)
- Diet with Colorectal Cancer (M. Guinter)
- Biomarkers May Improve Prediction (Y Wang)
- Kickstart NSCLCs Clinical Trials (L. Eichner)
- Mapping Mitochondria's “Dance” (D. Shackleford)
- E-Cig Use Ages 18 to 29 (P. Bandi)
- Stopping Smoking Earlier in Life (F Islami)
- Most with Lung Cancer Smoked (A Jemal)
- Furthering Lung Cancer Screening & Equity (S Fedewa)
- Mouse Lung Organoids for Research (C Kim)
- Quality of Life for Lung Cancer Survivors (J Temel)
- Precision Therapies for NSCLC (P Jänne)
- Cancer Deaths from Smoking (F Islami)
- Lung Cancer Surgery Disparities (A Jemal)
- BRG1-Deficient Lung Cancers (C Kim)
- Yoga for Couples with Lung Cancer (K Milbury)
- Metabolic Differences as New Drug Targets (A Marcus)
- CPS-II & CPS-3 Inform About Risks of Ovarian Cancer
- Machine Learning & Glowing Nanosensors (D Heller)
- Ovarian Cancer May Start in Fallopian Tube Cells (K Lawrenson)
- New Gene Linked with Deadliest Type (C Han)
- Gene-Testing Tools May Personalize Care (A Sood)
- Chromosome-Hoarding Ovarian Cancer Cells & Treatment (J Sheltzer)
- Nanoparticles as Drug Delivery for Metastases (X Lu)
- Turning Off 2 Proteins to Slow HGSC (P Kreeger)
- Targeted Light Therapy in Mice (M Bai)
- Nanoparticles, CAR T, and CRISPR (M Stephan)
- Endometriosis & Ovarian Cancer in Mice (M Wilson)
- Ovarian Cancer Special Section
- UV Exposure, Melanoma, & Dark Skin Types (A. Adamson)
- Melanoma and Lipid Droplets (R. White)
- Zebrafish and Acral Melanoma (R. White)
- T-Cell Lymphoma and PD1 (J. Choi)
- New Drug Destroys Cancer-Causing Protein (C. Crews)
- Virus & Merkel Cell Skin Cancer (R. Wang)
- Non-Genetic Drug Resistance (S. Spencer)
- Hijacking the Body's Sugar (R. Wang)
- Telling about High Risk (P. Kanetsky)
- Brain Metastasis and Alzheimer’s (E. Hernando)
- Exhausted Melanoma "Killer" Cells (W. Cui)
Stopping Smoking Earlier in Life Reduces More Risks
People who stop smoking by age 35 reduce almost 100% of the extra risk they had of dying from cancer or any other cause.
The Challenge
Smoking is still the major reason people die from cancer. Research has shown that people who start smoking when they are younger have a greater risk of dying than those who start later.
Quitting smoking (especially at younger ages) greatly reduces that risk. Nevertheless, there are still 34 million adults in the United States who still smoke cigarettes.
Statistics about how the age people are when they start and quit smoking affects their risk of death need to be updated for a contemporary population in the US. A specific gap in the current knowledge has been population-specific evidence on the benefits of quitting smoking among groups historically under-represented in medical research.
Research has shown that the patterns of smoking and smoking cessation differ markedly among people in different demographic groups. But there has been little research done to quantify the race-, ethnicity-, and sex-specific links of smoking with death.
The Research
Farhad Islami, MD, PhD, the senior scientific director of Cancer Disparity Research at the American Cancer Society (ACS), was the senior author of 2 recent studies. The first, in JAMA Oncology, reviewed data to get more current information about how the age people start and stop smoking is linked with the risk of dying from cancer. The second, in JAMA Network Open, looked at differences in smoking based on race, ethnicity, and sex and the risk of dying from any cause, including cancer.
For each study, the research team used data from the US National Health Interview Survey and the National Death Index, but age ranges and years studied varied between the two. In each case, there were more than 400,000 participants who were followed for an average of 10 or 11 years. The combined age ranges for the studies were between the ages of 25 and 84.
Our results clearly show harms from smoking and health benefits from quitting smoking among men and women of all racial ethnic groups and all ages, especially younger age groups.”
Farhad Islami, MD, PhD
Senior Scientific Director, Cancer Disparity Research
Surveillance and Health Equity Science, American Cancer Society
Age
Islami and his fellow researchers found that people who were currently smoking were 3 times more likely to die from cancer compared to those who never smoked.
They also found that smoking would account for:
- 75% of deaths from cancer among those who started smoking when they were younger than age 10
- 59% of deaths from cancer among those who started smoking when they were age 21 or older
More broadly, Islami and his team reported that among people who were currently smoking, about 70% of deaths from cancer, 60% of deaths from heart disease, and more than 90% of deaths from lower respiratory disease were attributable to smoking.
People who quit smoking between the ages of:
- 15 to 34 avoided about 100% of the extra risk of dying from cancer they would have had if they’d continued to smoke
- 35 to 44 avoided about 89% to 90% of the extra risk of dying from cancer they would have had if they’d continued to smoke
- 45 to 54 avoided about 78% of the extra risk of dying from cancer they would have had if they’d continued to smoke
- 55 to 64 avoided about 56% of the extra risk of dying from cancer they would have had if they’d continued to smoke
These results show that stopping smoking, even at an older age, greatly reverses the risk of dying from cancer. People who delayed smoking until they were adults had a greatly reduced risk of dying from cancer compared to those who started smoking at a younger age. Still, those who started smoking at age 21 and older had 2 times the risk of dying from cancer compared with those who never smoked.
Race/Ethnicity and Sex
The researchers also found that compared with people who never smoked, people who currently smoked had different risks of death based on their race and ethnic group.
- White people who smoked were 3 times more likely to die than White people who never smoked.
- Black people, Hispanic, and other non-Hispanic groups were 2 times more likely to die than people who never smoked.
- 31% of all deaths among White men and 22% of all deaths among White women were attributable to smoking.
- 27% of all deaths among Black men and 19% of all deaths among Black women were attributable to smoking.
- 20% of all deaths among Hispanic men and 11% of all deaths among Hispanic women were attributable to smoking.
The researchers note that the relatively lower risk of dying among Black and Hispanic groups was likely because, compared to White people, they smoked fewer cigarettes a day on average, were less likely to smoke every day, and began smoking at slightly older ages .
The benefits of quitting, however, were consistent among men and women from diverse racial and ethnic groups, particularly among those who quit smoking before age 45.
Islami was helped by Ahmedin Jemal, DVM, PhD, and former ACS Surveillance & Health Equity Science team member, Blake Thomson, DPhil, who led both papers when working at the ACS. Islami and Thomson collaborated with scientists from the University of Oxford in the United Kingdom.
Why It Matters
The findings from this study show once again that starting to smoke at any age is “extremely hazardous.” But they also show that the younger someone is when they quit smoking, the more they can lower their risk of dying from cancer or any other cause.
The problem is that recent progress in increasing the percentage of people who quit smoking in the US has been modest.
The researchers conclude, “broad and equitable tobacco cessation support for individuals who currently smoke, coupled with tobacco control policies that prevent the next generation from starting to smoke, may avert considerable premature smoking-related mortality in the coming decades if successful.”
Having specific information about the links between age-, race-, ethnicity-, and sex-specific links with smoking and death allows for health policy planning and for providing targeted messages, especially for groups historically underrepresented in medical research. And such personalized efforts may better motivate population-specific groups to quit smoking.